PARSIPPANY, N.J., April 13, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has formally designated its Parsippany, New Jersey facility as its Corporate Headquarters. The Company's new Corporate Headquarters address is Morris Corporate Center III, 400 Interpace Parkway, Parsippany, NJ 07054.
Previously, Watson Corporate Headquarters was located at 311 Bonnie Circle, Corona, CA 92880. Executive Offices and Commercial Headquarters were located at 360 Mt. Kemble Avenue, Morristown, NJ 07962.
The Company's new Corporate Headquarters occupies an entire building within a multi-tenant corporate office campus as well as a floor of an adjacent building and totals approximately 148,700 square feet. Watson is in the final stages of relocating all New Jersey employees from various facilities to the new site. The new facility enables Watson to combine the operations currently in separate facilities in the Morristown, NJ area into a larger space allowing the Company to more efficiently manage its growing global generic and brand pharmaceutical and biologics businesses around the world.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is a leading integrated global pharmaceutical company. The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.
For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.